The Food and Drug Administration today reported 55 injuries and one death involving an infusion pump and vital signs monitoring system. Becton Dickinson CareFusion 303 Inc. recalled the Alaris Infusion Pump System and Modules in February due to software and other errors that can delay, speed or interrupt the infusion of medications and other fluids to patients. According to FDA, consumers should follow the manufacturer’s recommended actions to help mitigate the potential risk of errors until the software issues have been remediated. Health care providers may report associated adverse reactions or quality problems to FDA’s MedWatch reporting program.

Related News Articles

Headline
As part of National Minority Health Month (April), AHA shares takeaways from a conversation with the Henry Ford Health System and Islamic Center of America…
Headline
The AHA and Black Coalition against COVID April 21 at 7 p.m. ET will host a town hall on enhancing the opportunities for rural health care providers, public…
Headline
During the COVID-19 pandemic, the University of California San Francisco Department of Obstetrics, Gynecology & Reproductive Sciences tested a new survey…
Headline
Last week at AHA’s Amplifying the Voices of Mothers event, experts from across the health care field engaged in a national conversation dedicated to maternal…
Blog
On April 7, the American Hospital Association brought together experts from across the health care field for a national conversation dedicated to maternal…
Headline
As part of its recognition of Black Maternal Health Week (April 11-17), the Department of Health and Human Services through the Centers for Medicare &…